Alzheimer's-Linked Protein May Help Melanoma Spread to Brain | FDA Approval for Prostate Cancer - Cancer Currents Blog

The latest from the NCI Cancer Currents blog

Having trouble viewing this email? View it as a Web page.

You are subscribed to Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Recent posts are listed below.     Alzheimer's-Linked Protein May Help Melanoma Spread to Brain 04/01/2022 Melanoma cells that travel to the brain produce their own amyloid beta, helping the cells survive and form metastases, a new study in mice shows. The Alzheimer's-linked proteins appear to tamp down the brain's immune response to the cancer cells. UPDATE: Radiopharmaceutical Drug Approved for Advanced Prostate Cancer An update has been made to a June 2021 Cancer Currents story on a clinical trial of 177Lu-PSMA-617, a type of drug known as a radiopharmaceutical, in men with advanced prostate cancer. On March 23, the Food and Drug Administration approved 177Lu-PSMA-617, which will be marketed as Pluvicto, based on the results of that clinical trial.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp       Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892